This test is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). Limitations NASH FibroSure® is recommended for patients with suspected nonalcoholic fatty liver disease. It is not recommended for patient with other liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis.
Specimen Type
Blood
Container
Gold Top Tube
Collection Instructions
Container/Tube: Red or Gold top tube Specimen: 3.5 mL serum ( 2 mL min) Transport Temperature: Refrigerated
Note: Patient should be fasting for at least eight hours Causes for Rejection Gross hemolysis; gross lipemia; improper labeling; nonfasting specimen; patient younger than 14 years of age
Transport Instructions
Refrigerated
Specimen Stability
3 Days Room Temperature or Refrigerated 7 Days Frozen
.
Methodology
The analytes tested are performed by FibroSure-Specific methods.
